Full coverage· Tech· Updated
Israeli Diabetes App MODI Receives Landmark FDA Clearance
Israeli company DreaMed Diabetes has received FDA clearance for its MODI app, which optimizes insulin dosing for type 2 diabetes patients using injections. The app is named in memory of Modi Amir, who was killed on October 7, and is part of an initiative to memorialize victims through innovation.
4 newsrooms · 2 languages · since
Plus
What happened
- 01Israeli startup DreaMed Diabetes received FDA clearance for its MODI insulin dosing app.
- 02MODI is the first FDA-cleared app for optimizing insulin injections for type 2 diabetes.
- 03The app provides personalized insulin recommendations directly to patients' smartphones.
- 04It addresses a gap in diabetes care for the 85% of users who rely on injections.
- 05The app is named in memory of Modi Amir, a victim of the October 7 attacks.
The Jerusalem Post publishes in English. The key points are summarized above. Read The Jerusalem Post’s full report from the link below.
The coverage
4 newsrooms on this story
Who covered it
- LeftNone
- Centre2
- RightNone
- HarediNone
- ArabNone
- Other2
How it broke
See which of the 4 newsrooms broke it, and who waited